propafenone has been researched along with Ectopic Junctional Tachycardia in 9 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propafenone is a sodium channel blocking agent with a mild beta- and calcium channel-blocking activity." | 6.39 | Guidelines for the use of propafenone in treating supraventricular arrhythmias. ( Camm, AJ; Kishore, AG, 1995) |
| " Dosage and serum levels of propafenone did not differ whether the patients were treated successfully or not." | 5.29 | Clinical experience with propafenone for cardiac arrhythmias in the young. ( Bourgeous, M; Heusch, A; Kramer, HH; Krogmann, ON; Rammos, S, 1994) |
| "Like other automatic tachyarrhythmias, junctional ectopic tachycardia has been shown to be very resistant to medical treatment." | 5.28 | [Effectiveness of propafenone in congenital ectopic junctional tachycardia--a case report]. ( Kallfelz, HC; Paul, T; Reimer, A, 1992) |
| "Propafenone was given orally in a mean dose of 350 (300 to 500) mg/m2 body surface area per day." | 2.67 | Efficacy and safety of propafenone in congenital junctional ectopic tachycardia. ( Janousek, J; Kallfelz, HC; Paul, T; Reimer, A, 1992) |
| "Propafenone is a sodium channel blocking agent with a mild beta- and calcium channel-blocking activity." | 2.39 | Guidelines for the use of propafenone in treating supraventricular arrhythmias. ( Camm, AJ; Kishore, AG, 1995) |
| "To evaluate treatment of junctional ectopic tachycardia after cardiac surgery." | 1.31 | [The treatment of postoperative junctional ectopic tachycardia]. ( Cabrera Duro, A; Galdeano Miranda, JM; Macua Biurrun, P; Martínez Corrales, P; Pastor Menchaca, E; Pilar Orive, J; Rodrigo Carbonero, D, 2002) |
| " Dosage and serum levels of propafenone did not differ whether the patients were treated successfully or not." | 1.29 | Clinical experience with propafenone for cardiac arrhythmias in the young. ( Bourgeous, M; Heusch, A; Kramer, HH; Krogmann, ON; Rammos, S, 1994) |
| "Postoperative junctional ectopic tachycardia is associated with a poor prognosis in patients after open-heart surgery." | 1.29 | [Therapy of postoperative ectopic junctional tachycardia by surface hypothermia]. ( Kallfelz, HC; Paul, T; Wilken, M; Ziemer, G, 1993) |
| "Propafenone was administered to 58 patients with a mean age of 3." | 1.28 | Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias. ( Kallfelz, HC; Paul, T; Reimer, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarubbi, B | 1 |
| Musto, B | 1 |
| Ducceschi, V | 1 |
| D'Onofrio, A | 1 |
| Cavallaro, C | 1 |
| Vecchione, F | 1 |
| Musto, C | 1 |
| Calabrò, R | 1 |
| Heusch, A | 1 |
| Kramer, HH | 1 |
| Krogmann, ON | 1 |
| Rammos, S | 1 |
| Bourgeous, M | 1 |
| Wilken, M | 1 |
| Paul, T | 4 |
| Ziemer, G | 1 |
| Kallfelz, HC | 4 |
| Kishore, AG | 1 |
| Camm, AJ | 1 |
| Cabrera Duro, A | 1 |
| Rodrigo Carbonero, D | 1 |
| Galdeano Miranda, JM | 1 |
| Martínez Corrales, P | 1 |
| Pastor Menchaca, E | 1 |
| Macua Biurrun, P | 1 |
| Pilar Orive, J | 1 |
| Reimer, A | 3 |
| Janousek, J | 1 |
| Garson, A | 1 |
| Moak, JP | 1 |
| Smith, RT | 1 |
| Norton, JB | 1 |
1 review available for propafenone and Ectopic Junctional Tachycardia
| Article | Year |
|---|---|
Guidelines for the use of propafenone in treating supraventricular arrhythmias.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Surgical Procedure | 1995 |
1 trial available for propafenone and Ectopic Junctional Tachycardia
| Article | Year |
|---|---|
Efficacy and safety of propafenone in congenital junctional ectopic tachycardia.
Topics: Drug Evaluation; Electrocardiography; Electrocardiography, Ambulatory; Follow-Up Studies; Humans; In | 1992 |
7 other studies available for propafenone and Ectopic Junctional Tachycardia
| Article | Year |
|---|---|
Congenital junctional ectopic tachycardia in children and adolescents: a 20 year experience based study.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Digoxin; Drug Therapy, Combination; Female; H | 2002 |
Clinical experience with propafenone for cardiac arrhythmias in the young.
Topics: Administration, Oral; Adolescent; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Complexes, Premature | 1994 |
[Therapy of postoperative ectopic junctional tachycardia by surface hypothermia].
Topics: Combined Modality Therapy; Digitalis Glycosides; Electrocardiography, Ambulatory; Heart Conduction S | 1993 |
[The treatment of postoperative junctional ectopic tachycardia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Combined Modality Therapy; Female; | 2002 |
[Effectiveness of propafenone in congenital ectopic junctional tachycardia--a case report].
Topics: Child, Preschool; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Follow-Up Studi | 1992 |
Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dysrhythmias.
Topics: Administration, Oral; Adolescent; Arrhythmias, Cardiac; Child; Child, Preschool; Electrocardiography | 1991 |
Usefulness of intravenous propafenone for control of postoperative junctional ectopic tachycardia.
Topics: Child, Preschool; Heart Defects, Congenital; Heart Rate; Humans; Infant; Infant, Newborn; Injections | 1987 |